The Global Breast
Lesion Localization Methods Market, By Technique (Wire Guided Localization,
Radio Guided Occult Lesion Localization, Radioactive Seed Localization,
Magnetic Tracers, and Ultrasound Guided Surgery), End User (Hospitals,
Specialized Clinics, Research Institutes, and Ambulatory Surgical Centers), and
by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa), was valued at US$ 530.2 million in 2018 and is projected to exhibit a
CAGR of 10.7% over the forecast period (2019 – 2027).
Increasing incidence and prevalence
of breast cancer is expected to drive growth of the global breast lesion
localization methods market
According to WHO report published
in 2018, breast cancer is the most frequent cancer among women, impacting 2.1
million women each year though the world. It is estimated that around 627,000
women died due to breast cancer, which is around 15% of all cancer deaths among
women globally. Moreover, increasing government initiatives to increase
awareness about breast cancer in developed and emerging regions is also
expected to propel growth of the breast lesion localization methods market
during the forecast period. For instance, according to The Pink Initiative and
Breast Cancer Statistics in India, in 2014, a significantly large population of
patients below the age of 50 years suffered from breast cancer.
Around 16% were between the age
of 20 and 40, and 28% were between the age of 40 and 50. Increasing patient
population in such regions with high potential is expected to improve the time
to market of highly effective and advanced products. Furthermore, increasing
number of mergers and acquisitions is also expected to drive growth of the
global breast lesion localization methods market during the forecast period.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/104
For instance, in January 2019,
IZI Medical Products acquired select soft tissue biopsy and breast localization
needle assets from Cook Medical. The acquisition is expected to expand product
portfolio of IZI Medical Products with addition of MReye Breast Localization
Coil.
Browse 32 Market Data Tables and
28 Figures spread through 175 Pages and in-depth TOC on ‘Breast Lesion
Localization Methods Market, By Technique (Wire Guided Localization, Radio
Guided Occult Lesion Localization, Radioactive Seed Localization, Magnetic
Tracers, and Ultrasound Guided Surgery), End User (Hospitals, Specialized
Clinics, Research Institutes, and Ambulatory Surgical Centers), and by Region
(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
Global Forecast to 2027”
Increasing incidence and
prevalence of breast cancer has led to rising demand for breast cancer lesion
localization products. Therefore, manufactures are expanding their product
portfolio and geographical reach by increasing product launches and approvals.
For instance, in March 2019, Hologic received CE certification for its
LOCalizer wireless radiofrequency identification breast lesion localization
system. The system is designed to replace wire-guided breast lesion localization
technique. Key players in the market are focused on adopting strategies such as
partnerships and acquisitions to expand their product portfolio and
geographical presence in the global breast lesion localization methods market.
For instance, in July 2018, Hologic Inc. announced that it completed the
acquisition of Faxitron Bioptics, a privately held leader in digital specimen
radiography, breast lesion localization, and sentinel lymph node biopsy.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/breast-lesion-localization-methods-market-104
Key Takeaways of the Breast
Lesion Localization Methods Market:
The global breast lesion
localization methods market is expected to exhibit a CAGR of 10.7% over the
forecast period, owing to increasing incidence of breast cancer, increasing
government initiative to promote awareness, and increasing product launches. For
instance, according to the American Cancer Society reports published in 2019,
around 268,600 new cases of invasive breast cancer will be diagnosed in women
during 2019 and the incidence rate increased by 0.4% per year.
Among technique, the wire guided
localization segment exhibited highest CAGR in the global breast lesion
localization methods market in 2018. This growth was due to the early
establishment and higher adoption of this technique among end users.
Among end user, the hospital
segment held dominant position in the global breast lesion localization methods
market in 2017, owing to favorable reimbursement policies. According to
American Cancer Society, one time screening mammogram every 12 months is
covered fully under Medicare for all women aged 40 years and older. Also, it
pays for clinical breast exam (CBE) in every 24 months once, for women with
average risk of breast cancer. This in turn is expected to increase rate of
breast cancer screening and in turn drive growth of the breast lesion localization
methods market in the near future.
Key players operating in the
global breast lesion localization methods market include Cook Medical Inc.,
Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard),
SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, Hologic
Inc., and Tsunami S.r.l.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/104
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200 Seattle,
WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment